Company News
Company statement
Industry News
欧博方研发的中国首款猫用高选择性NSAIDs专利药,猫专用贝安可于2020年5月22日获得新兽药批准文号,6月上市。
About Orbiepharm
R&D and Manufacture
Marketing Center
Products
Classroom
News & Information
Contact Us
Follow Us